Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.
“I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management Board. Together with him and Dr. Lukas Burkhardt, we make a strong Management Board team that will drive Gerresheimer’s sustainable growth forward,” says Dietmar Siemssen, CEO of Gerresheimer AG.
After studying business administration in Siegen, Germany, completing his doctorate and starting his career at a law firm, Dr. Metzner held various management positions in finance at the Bayer Group between 2002 and 2011. Among other roles, he was responsible for coordinating the carveout and initial public offering of Lanxess, and held the position of CFO at Bayer Italy as well as that of global CFO in Bayer’s Pharmaceuticals Division. Before joining Ströer, he served as CFO of the global, familyowned Döhler Group from mid-2011 to mid-2014.
The Management Board of Gerresheimer AG (as of May 15, 2019):
15.05.2019, Gerresheimer AG
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.